Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Olanzapine Monotherapy for Treatment Bipolar Ⅰ Depression: a Randomized, Double-blind, Placebo Controlled Study

NCT01303601 is registered in ClinicalTrials.gov with China Medical University, China as lead sponsor.

NCT NCT01303601
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01303601 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Olanzapine Monotherapy for Treatment Bipolar Ⅰ Depression: a Randomized, Double-blind, Placebo Controlled Study
Lead sponsor
China Medical University, China
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2009
Completion date
October 31, 2010
Enrollment
68 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, depression, bipolar